Fortis Healthcare is currently trading at RS. 933.00, up by 8.15 points or 0.88% from its previous closing of RS. 924.85 on the BSE.

The stock opened at RS. 934.95 and touched a high of RS. 934.95 and a low of RS. 920.20. A total of 5038 shares have been traded so far.

A BSE group 'A' stock with a face value of RS. 10, Fortis Healthcare hit a 52-week high of RS. 971.00 on August 21, 2025, and a 52-week low of RS. 521.05 on April 7, 2025. In the past week, the stock recorded a high of RS. 934.95 and a low of RS. 904.75. The company’s current market capitalization is RS. 69875.15 crore.

The shareholding pattern shows 31.17% held by promoters, 56.96% by institutions, and 11.87% by non-institutions.

Fortis Healthcare’s wholly-owned subsidiary, International Hospital (IHL), has signed a 15-year lease agreement with RR Lifesciences for a fully operational 200-bed multi-specialty hospital in Greater Noida. The company had earlier managed this facility under an Operations & Management (O&M) arrangement since its launch in October 2022. Under the new agreement, it will continue operations as Fortis Hospital Greater Noida.

With this move, Fortis will assume full operational and financial control, consolidating the hospital’s performance within its network. The hospital is situated on a 1.35-acre UPSIDA-leased land parcel with 2.7 lakh sq. ft. built-up area and has potential for an additional 50 beds, taking capacity up to 250 beds. Strategically located, the facility is well connected via the Greater Noida Expressway, Metro Aqua Line, Yamuna Expressway, and Eastern Peripheral Expressway, and lies just 34 km from the upcoming Jewar International Airport.

Fortis Healthcare is one of Asia’s leading integrated healthcare providers, with services across primary care, diagnostics, day care specialties, and hospitals, operating through a strong network in multiple countries.